Versant Capital Management’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$119K Buy
2,667
+2,312
+651% +$83.2K 0.01% 836
2026
Q1
$11.4K Buy
355
+44
+14% +$1.56K ﹤0.01% 2081
2025
Q4
$11.2K Buy
311
+177
+132% +$6.5K ﹤0.01% 1945
2025
Q3
$4.22K Sell
134
-80
-37% -$2.87K ﹤0.01% 2274
2025
Q2
$9.11K Buy
214
+211
+7,033% +$8.78K ﹤0.01% 1924
2025
Q1
$134 Hold
3
﹤0.01% 2481
2024
Q4
$165 Buy
+3
New +$152 ﹤0.01% 2337

Other funds holding VCEL

Versant Capital Management's VCEL Position: Q2 2026 in Review

Versant Capital Management increased its Vericel Corp (VCEL) stake by 651% in Q2 2026, buying an estimated $83.2K and bringing the position to 2,667 shares worth $119K. The position accounts for 0.01% of the portfolio, ranked #836.

Versant Capital Management first reported a position in VCEL in Q4 2024 and has held it in 7 quarters since. 22 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

  • Versant Capital Management held 2,667 shares of Vericel Corp worth $119K as of Q2 2026.
  • Versant Capital Management bought 2,312 Vericel Corp shares in Q2 2026, an estimated $83.2K.
  • Vericel Corp made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #836 holding.
  • Versant Capital Management first reported a position in Vericel Corp in Q4 2024 and has held it in 7 quarters since.
  • 22 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.